Basit öğe kaydını göster

dc.contributor.authorDoğan, Ismail
dc.contributor.authorKalyoncu, Umut
dc.contributor.authorKiliç, Levent
dc.contributor.authorAkdoğan, Ali
dc.contributor.authorKaradağ, Omer
dc.contributor.authorKiraz, Sedat
dc.contributor.authorA Bilgen, Şule
dc.contributor.authorErtenli, Ihsan
dc.date.accessioned2021-03-18T07:41:47Z
dc.date.available2021-03-18T07:41:47Z
dc.date.issued2020-02-13
dc.identifier.citationDoğan, I., Kalyoncu, U., Kiliç, L., Akdoğan, A., Karadağ, Ö., Kiraz, S., Bilgen, Ş. A., & Ertenli, I. (2020). Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid. Turkish journal of medical sciences, 50(1), 219–224. https://doi.org/10.3906/sag-1908-182tr_TR
dc.identifier.urihttps://doi.org/10.3906/sag-1908-182
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080371/
dc.identifier.urihttps://journals.tubitak.gov.tr/medical/issues/sag-20-50-1/sag-50-1-29-1908-182.pdf
dc.identifier.urihttp://hdl.handle.net/11655/23574
dc.description.abstractBackground/aim: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus (SLE) is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. Materials and methods: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology (ACR) revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. Results: AVN was found in 11 of 127 (8.7%) SLE patients. Hyperlipidemia (P < 0.001), cushingoid body habitus (P < 0.001), and proteinuria (P = 0.013) were found at higher rates in the AVN group. All of the 11 AVN cases had osteoporosis (P < 0.02). In multivariate regression analysis, daily steroid usage was the only factor for development of AVN in SLE. Conclusion: The hypothesis of our study was that an alternate day steroid regimen may decrease AVN frequency in SLE patients.tr_TR
dc.language.isoentr_TR
dc.publisherTÜBİTAKtr_TR
dc.relation.isversionof10.3906/sag-1908-182tr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.subjectsystemic lupus erythematosustr_TR
dc.subjectalternate day steroid usagetr_TR
dc.subjectAvascular necrosistr_TR
dc.subject.lcshTıp uygulamasıtr_TR
dc.titleAvascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroidtr_TR
dc.typeinfo:eu-repo/semantics/articletr_TR
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalTurk J Med Scitr_TR
dc.contributor.departmentİç Hastalıklarıtr_TR
dc.identifier.volume50tr_TR
dc.identifier.issue1tr_TR
dc.identifier.startpage219tr_TR
dc.identifier.endpage224tr_TR
dc.description.indexPubMedtr_TR
dc.fundingYoktr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess